We are live on ! Find out more
CPAH

Counterpath Corp
CPAH

Delisted

CPAH was delisted on the 26th of February, 2021.

6 hedge funds and large institutions have $665K invested in Counterpath Corp in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less capital invested

Capital invested by funds: $713K → $665K (-$48K)

14% less funds holding

Funds holding: 76 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$1.23K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$642K
Bank of Montreal
2
Bank of Montreal
Ontario, Canada
$20K
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$3K
TRCT
4
Tower Research Capital (TRC)
New York
-$1.23K -500 -83%

CPAH Hedge Fund Activity: Q1 2017 in Review

6 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q1 2017, worth a combined $665K — down 6.7% from $713K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CPAH and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Tower Research Capital (TRC), cutting an estimated $1.23K.

  • 6 institutional investors held Counterpath Corp (CPAH) as of Q1 2017, down from 7 in Q4 2016.
  • Funds reported $665K of Counterpath Corp stock for Q1 2017, down 6.7% quarter-over-quarter.
  • 0 funds opened new Counterpath Corp positions in Q1 2017 and 1 closed out, a net change of -1 holder.
  • The largest Counterpath Corp seller in Q1 2017 was Tower Research Capital (TRC), an estimated $1.23K sold.

Based on aggregated 13F filings for Q1 2017.